Ablynx burns more cash in first half of 2015
August 27, 2015 at 02:03 AM EDT
BRUSSELS, Aug 27 (Reuters) - Belgian biotech firm Ablynx burnt through more cash in the first half of 2015, as it increased spending on research and clinical trials for its experimental drugs.
